G-CSF therapy for acute myocardial infarction

Trends in Pharmacological Sciences

Volumn 28, Issue 10, 2007, Pages 512-517

  Takano, Hiroyuki ^a   Ueda, Kazutaka ^a   Hasegawa, Hiroshi ^a   Komuro, Issei ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; PROTEIN KINASE B; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STAT3 PROTEIN;

ACUTE HEART INFARCTION; ARTICLE; BLOOD VESSEL; CELL DEATH; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; CELL REGENERATION; CLINICAL TRIAL; DRUG MECHANISM; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE REMODELING; HEMATOPOIETIC STEM CELL; HUMAN; IMMOBILIZED CELL; LOW DRUG DOSE; LYMPHOCYTE COUNT; MEDICAL LITERATURE; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; SIGNAL TRANSDUCTION;

ACUTE DISEASE; CLINICAL TRIALS AS TOPIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MYOCARDIAL INFARCTION; VENTRICULAR FUNCTION, LEFT;

EID: 34748897802     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2007.09.002     Document Type: Article

References (41)

1. Heart disease and stroke statistics - 2007 update, American Heart Association, 2007
2. Orlic D., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
3. Kocher A.A., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7 (2001) 430-436
4. Mangi A.A., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9 (2003) 1195-1201
5. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 103 (2004) 1580-1585
6. Orlic D., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10344-10349
7. Murry C.E., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
8. Balsam L.B., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
9. Nygren J.M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10 (2004) 494-501
10. Ohtsuka M., et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J. 18 (2004) 851-853
11. Harada M., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat. Med. 11 (2005) 305-311
12. Sugano Y., et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc. Res. 65 (2005) 446-456
13. Minatoguchi S., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109 (2004) 2572-2580
14. Kawada H., et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104 (2004) 3581-3587
15. Lehrke S., et al. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ. Res. 99 (2006) 553-560
16. Yamauchi-Takihara K., and Kishimoto T. A novel role for STAT3 in cardiac remodeling. Trends Cardiovasc. Med. 10 (2000) 298-303
17. Hilfiker-Kleiner D., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ. Res. 95 (2004) 187-195
18. Oshima Y., et al. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc. Res. 65 (2005) 428-435
19. Miyata S., et al. Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am. J. Pathol. 168 (2006) 386-397
20. Ueda K., et al. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler. Thromb. Vasc. Biol. 26 (2006) e108-e113
21. Schulz R., et al. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc. Res. 61 (2004) 402-413
22. Iwanaga K., et al. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem. Biophys. Res. Commun. 325 (2004) 1353-1359
23. Takahama H., et al. Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts. Cardiovasc. Drugs Ther. 20 (2006) 159-165
24. Kang H.J., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
25. Hill J.M., et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J. Am. Coll. Cardiol. 46 (2005) 1643-1648
26. Hasegawa H., et al. G-CSF prevents the progression of atherosclerosis and neointimal formation in rabbits. Biochem. Biophys. Res. Commun. 344 (2006) 370-376
27. Kong D., et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 110 (2004) 2039-2046
28. Yoshioka T., et al. Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc. Res. 70 (2006) 61-69
29. Takamiya M., et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 751-757
30. Li Y., et al. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats. Eur. J. Pharmacol. 549 (2006) 98-106
31. Kuethe F., et al. Treatment with granulocyte colony-stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction. Am. Heart. J. 150 (2005) 115
32. Valgimigli M., et al. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur. Heart J. 26 (2005) 1838-1845
33. Ince H., et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112 (2005) 3097-3106
34. Nienaber C.A., et al. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans. Nat. Clin. Pract. Cardiovasc. Med. 3 Suppl. 1 (2006) S73-S77
35. Zohlnhofer D., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA. 295 (2006) 1003-1010
36. Shintani S., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
37. Schomig K., et al. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur. Heart J. 27 (2006) 1032-1037
38. Schachinger V., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1210-1221
39. Ripa R.S., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
40. Takano H., et al. Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. Int. J. Cardiol. (2006). http://www.elsevier.com/locate/ijcard 10.1016/j.ijcard.2006.11.016
41. Engelmann M.G., et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J. Am. Coll. Cardiol. 48 (2006) 1712-1721